Health Professional Radio - Podcast

Dr. Bettina Cockroft, M.D., SVP and CMO at Sangamo Therapeutics, Inc., a gene therapy company, discusses their approach to treating disease and why genomic medicines are so important to the future of medicine. She also talks about one of the latest therapies Sangamo has in a Phase 1/2 clinical trial for the treatment of Fabry disease, a rare, X-linked lysosomal storage disorder caused by a gene mutation in an enzyme responsible for breaking down fatty substances.